Rubric Capital Management LP Amarin Corp Plcuk Transaction History

Rubric Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$4.78 - $8.26 $3.35 Million - $5.78 Million	-700,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$4.0 - $21.53 $923,068 - $4.97 Million	-230,767 Reduced 24.79%	700,000 $2.8 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $28.3 Million - $49 Million	-2,030,996 Reduced 68.57%	930,767 $20 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $3.64 Million - $6.06 Million	261,763 Added 9.69%	2,961,763 $44.9 Million
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $7.32 Million - $9.23 Million	450,000 Added 20.0%	2,700,000 $52.4 Million

Q1 2019 May 10, 2019	BUY	$12.61 - $22.33 $11.4 Million - $20.2 Million	904,624 Added 67.24%	2,250,000 $46.7 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $8.01 Million - $14.8 Million	645,376 Added 92.2%	1,345,376 $18.3 Million
Q3 2018 Nov 13, 2018	BUY	$2.45 - $16.27 $1.72 Million - $11.4 Million	700,000 New	700,000 $11.4 Million

3.55M

36.9K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.59B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.